Skip Navigation
Wilmer Eye Institute
Print This Page
Share this page: More

Fuchs Dystrophy and Cataracts

Fuchs Dystrophy and Cataracts 

What is a cataract? 

A cataract is the clouding of the lens in the eye.  Normally, the lens helps focus the light onto the retina (the film on the back of the eye).  When the lens becomes clouded, the picture that the person sees becomes clouded, as well. 

Cataracts develop naturally among aging individuals. More than half of all people above sixty years old suffer from cataracts.  Removal of cataracts is the most common eye surgery.  1.4 million cataract surgeries are performed in the United States each year. 

A cataract

Cataract surgery involves removal of the entire lens.
It is usually replaced by an artificial lens.


Cataract surgery
From the files of John D. Gottsch, MD   

Nuclear cataracts

Nuclear Cataracts

Top Left:  Grade 1

Top Right:  Grade 2

Bottom Left:  Grade3

Bottom Right:  Grade 4





Note:  For further information on the use of
this cataract standard, doctors and
researchers should call the office of Sheila
West, PhD, at (410) 955-2606.                                                                                   

Fuchs Endothelial Corneal Dystrophy (FECD) and Cataracts

Some people with cataracts also have Fuchs Endothelial Corneal Dystrophy (FECD).  If a Fuchs patient undergoes cataract surgery, the fragile endothelial cells of the cornea may be damaged.  (The endothelial cells are those cells at the very back of the cornea.  The endothelial cells deteriorate in patients with FECD.)  The loss of too many of these cells can lead to edema (swelling) of the cornea.  This edema can then sometimes lead to painful corneal bullae (blisters), deterioration of vision, and eventually, the need for a corneal transplant. 

In summary, in a patient with FECD, a cataract surgery may hasten the need for a corneal transplant.  Because of this risk, the corneas of FECD patients are examined carefully before cataract surgery.  Sometimes, the eye doctor will decide that the patient should have both cataract surgery and a corneal transplant at the same time.  By doing this, two separate surgeries are combined into one procedure, and recovery time is greatly reduced.

Recent research has helped doctors figure out when a Fuchs patient can have simple cataract surgery and when a Fuchs patient should have a combined surgery (cataract surgery plus corneal transplant).  These researchers showed that many Fuchs patients with corneas thinner than 640 microns can usually have simple cataract surgery.  (A micron is a very tiny unit of measurement.  Each micron is 0.00004 inches long.) 

Whenever a person with FECD has cataract surgery, the surgeon uses special jelly-like material called viscoelastic gel.  Viscoelastic gel is put inside the eye to protect the back of the cornea during the surgery.  The viscoelastic gel is then taken out again at the end of the surgery.  This gel has been shown to greatly decrease endothelial cell loss during cataract surgery.

Ophthalmologic researchers are trying to figure out if there is a minimum number of endothelial cells that everyone has to have in order to see properly.  Preliminary research, however, indicates that no absolute number exists for this threshold value.  Instead, it seems to vary from patient to patient.

View video of cataract surgery Video of Cataract Surgery 

Fuchs and Laser Vision Correction

Any trauma to the cornea can be detrimental to the endothelium, and thereby cause Fuchs symptoms to worsen faster.  Fuchs patients are advised against undergoing cosmetic corneal surgery such as Laser Vision Correction.

To read a scientific paper on this subject, please click here.

Dr. Pradeep Ramulu and Colleagues Study Relationship Between Vision Loss and Work Status - 7/18/2014

Wilmer Resident Receives Lindstrom Research Grant - 7/11/2014

Four Wilmer Researchers Receive BrightFocus Foundation Awards - 7/10/2014

Dr. Michael Repka Part of Team Researching Telemedicine and ROP - 6/27/2014

Dr. M. Valeria Canto-Soler and Colleagues Featured on WBAL-TV - 6/24/2014

Dr. M. Valeria Canto-Soler and Colleagues Use Human Stem Cells to Create Light-Sensitive Retina in a Dish - 6/10/2014

Wilmer's Division of Ocular Immunology Announces "Living With Uveitis" Support Group - 6/10/2014

Dr. Neil Bressler to Speak on Diabetic Retinopathy at National Eye Health Summit and Webcast - 6/10/2014

Dr. Donald Zack Receives a Research to Prevent Blindness Nelson Trust Award for Retinitis Pigmentosa - 6/9/2014

Dr. Michael Boland Leads Study on Effectiveness of Automated Telecommunication-Based Reminders on Adherence to Glaucoma Medication Dosing - 6/4/2014

Dr. Christina Prescott Discusses Summer Eye Protection on Fox 45 News - 6/1/2014

Dr. Jonathan Song Discusses Treatment Options for Pediatric Cataracts - 5/23/2014

Johns Hopkins' Jordan Green Discusses His Work at Wilmer's Translational Tissue Engineering Center - 5/21/2014

Longtime Wilmer Employee Lillie Alston Honored by Hopkins - 5/19/2014

Dr. Richard Semba: Diets Rich in Antioxidant Resveratrol Fail to Reduce Deaths, Heart Disease or Cancer - 5/12/2014

Dr. Neil Miller Explains Eye Twitching in The Wall Street Journal - 5/12/2014

Dr. Hendrik Scholl Receives ARVO Award - 5/7/2014


Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

U.S. 1-410-464-6713 (toll free)
International +1-410-614-6424



© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer